secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pediatrix Medical Group, Inc. (MD)
CIK:        0000893949
Form:       8-K
Filed at:   2023-11-02T23:59:59+00:00
Accession:  0000950170-23-057732
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pediatrix Q3 GAAP EPS $0.26, Adjusted EPS $0.32; FY guidance $200-210M
----------------------------------------------------------------------

- Q3 GAAP EPS $0.26 vs $0.35 YoY; Adjusted EPS $0.32 vs $0.40.
- Net revenue $506.6M (+3.4% YoY) but same-unit patient volume declined 1.2%.
- Adjusted EBITDA $50.4M, down 13.5% from $58.3M; practice costs rose to $368.4M.
- FY2023 Adjusted EBITDA guidance $200-210M; first nine months $149.6M implies soft Q4.
- Terminated R1 RCM contract effective Dec 15, 2023; plans hybrid revenue cycle model.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/893949/000095017023057732/0000950170-23-057732-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/893949/000095017023057732/md-20231102.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-057732

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer